Your Guide to SMI Adviser – Advancing Interdisciplinary Care for Early Psychosis
Robert O. Cotes, MD & Sherin Khan LCSW
SMI Adviser is a 6-year initiative funded by the Substance Abuse and Mental Health Services Administration and administered by the American Psychiatric Association. SMI Adviser’s vision is to transform care for people who have serious mental illness so that they can live their best lives. To date, the website has been accessed over 1.9 million times and has been a resource for over 70,000 interdisciplinary learners. In this presentation, we will provide clinicians a guide to the resources at SMI Adviser, with a focus on resources for working with individuals with early psychosis. We will also highlight resources that are found in our Centers of Excellence section, focusing on tools in the Clozapine and Long-Acting Injectable areas. We will also guide clinicians through our consultation service and share insights from the types of questions our users most commonly ask.
Learning Objectives
Demonstrate knowledge of the available resources on SMI Adviser’s educational catalog and knowledge base.
List and describe three tools in SMI Adviser’s Clozapine or Long-Acting Injectable Center of Excellence.
Outline the process of accessing SMI Adviser’s consultation service, demonstrating the ability to effectively seek guidance to help make evidence-based treatment decisions.
Bio:
Robert O. Cotes, MD, is an Associate Professor at Emory University School of Medicine in the Department of Psychiatry and Behavioral Sciences. He serves as Physician Expert for SMI Adviser (www.smiadviser.org), which is funded by the Substance Abuse and Mental Health Services Administration and administered by the American Psychiatric Association. SMI Adviser provides evidence-based resources to clinicians, individuals with serious mental illness, and their families.
He is Director of the Clinical & Research Program for Psychosis at Grady Health System, which comprises of three clinical programs. The PSTAR Clinic provides evidence-based, recovery-oriented care for individuals with persistent symptoms of psychosis, specializing in the use of clozapine. Project ARROW is a coordinated specialty care team for people experiencing early psychosis, offering comprehensive, person-centered care using a multidisciplinary approach. Youth and Family TREE provides care to adolescents and young adults with a mental health condition and substance use. Dr. Cotes is an investigator for multiple research studies focused on treatment options for people with psychosis. His research focuses on clozapine and early psychosis.
SMI Adviser is a 6-year initiative funded by the Substance Abuse and Mental Health Services Administration and administered by the American Psychiatric Association. SMI Adviser’s vision is to transform care for people who have serious mental illness so that they can live their best lives. To date, the website has been accessed over 1.9 million times and has been a resource for over 70,000 interdisciplinary learners. In this presentation, we will provide clinicians a guide to the resources at SMI Adviser, with a focus on resources for working with individuals with early psychosis. We will also highlight resources that are found in our Centers of Excellence section, focusing on tools in the Clozapine and Long-Acting Injectable areas. We will also guide clinicians through our consultation service and share insights from the types of questions our users most commonly ask.
Sherin Khan, LCSW is Vice President of Operations and Strategy for Thresholds, Illinois’ oldest and largest provider of mental health services. Sherin also serves as the social work consultant as part of SMI Adviser, a SAMHSA funded clinical support system for people living with serious mental illness. She has over 10 years of experience in the non-profit sector with a focus on serving those who are disempowered. She received her Masters of Social Work degree from the University of Illinois at Chicago and excels at relationship management, strategic planning, leadership and organizational development, and change implementation. Expertise in clinical areas includes Cognitive Behavioral Therapy, Dialectical Behavioral Therapy, Acceptance and Commitment Therapy, and Motivational Interviewing.
Sherin has extensive knowledge of Certified Community Behavioral Healthcare Clinic (CCBHC) standards, guidelines, and reporting requirements, as well as experience in the implementation of CCBHCs developing necessary infrastructure and coordinating with collaborative partnerships to ensure access to comprehensive, integrated behavioral health services.
She has held both clinical and administrative leadership positions and excels at project management, process improvement, and designing and enacting programs and trainings to improve organizational and workforce effectiveness.
Zoom Link: https://harvard.zoom.us/meeting/register/tJ0vceCppjoqH9JDMxQoWVLoUR38_-nk-LGe
This webinar is hosted in collaboration with the New England MHTTC